Prostate sarcoma, particularly the pathological type of leiomyosarcoma, is a rare carcinoma, which originated from the interstitial tissue of the prostate. This sarcoma type has a poor prognosis. This disease accounts for ~0. 1% of all prostate cancer and it usually occurrs in patients aged between 40 and 78-years-old. Although prostate leiomyosarcoma has a poor prognosis, early treatment of post-operative recurrence and metastases via a whole-body examination and closer follow-up was possible. These measurements may significantly prolong the survival time and improve the quality of life. The present study reported a successful case of surgical management for prostate leiomyosarcoma in the Zigong No. 4 People's Hospital (Sichuan, China) during 1995 until 2015, with post-operative follow-up for 20 years.
Molecular and clinical oncology. 2016 May 11 [Epub]
Wei Chen, Deng-Jun Han, Guang-Qing Fu, Wei Lin, Yong Liang
Department of Urology, Zigong No. 4 People's Hospital, Zigong, Sichuan 643000, P.R. China., Department of Urology, Zigong No. 4 People's Hospital, Zigong, Sichuan 643000, P.R. China., Department of Urology, Zigong No. 4 People's Hospital, Zigong, Sichuan 643000, P.R. China., Department of Urology, Zigong No. 4 People's Hospital, Zigong, Sichuan 643000, P.R. China., Department of Urology, Zigong No. 4 People's Hospital, Zigong, Sichuan 643000, P.R. China.